KRISTINA BYRD: Open Payments
NPI 1326498338 · BOONEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 46 payments from 10 companies in 2025. Trend: 2023 $687 · 2024 $547 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $237 |
| ABBVIE INC. | 10 | $173 |
| Vanda Pharmaceuticals Inc. | 8 | $157 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Alkermes, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Phadia US Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Indivior Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, FANAPT, REXULTI, ARISTADA, QULIPTA, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
